Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhanqi Wei

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Immunology|September 18, 2023
Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinomaZhanqi Wei, Yajing Wang, Boyang Wu, et al.
Frontiers in Immunology|March 15, 2021
Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With MicroparticlesZhizhong Ren, Yuanxun Yue, Yuewei Zhang, et al.
ILIVER|July 10, 2025
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinomaYing Liu, Yaqin Wang, Zhanqi Wei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2022
Carma3 Protects from Liver Injury by Preserving Mitochondrial Integrity in Liver Sinusoidal Endothelial CellsLiqing Cheng, Zhanqi Wei, Zaopeng Yang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 4, 2025
Dissection of immunotherapeutic predictive versus prognostic transcriptional programs identifies SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-(L)1 treatment in non-small cell lung cancerYu-Ze Wang, Ning Gao, Zhanwen Lin, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Immunology|September 18, 2023
Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinomaZhanqi Wei, Yajing Wang, Boyang Wu, et al.
Frontiers in Immunology|March 15, 2021
Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With MicroparticlesZhizhong Ren, Yuanxun Yue, Yuewei Zhang, et al.
ILIVER|July 10, 2025
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinomaYing Liu, Yaqin Wang, Zhanqi Wei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2022
Carma3 Protects from Liver Injury by Preserving Mitochondrial Integrity in Liver Sinusoidal Endothelial CellsLiqing Cheng, Zhanqi Wei, Zaopeng Yang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 4, 2025
Dissection of immunotherapeutic predictive versus prognostic transcriptional programs identifies SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-(L)1 treatment in non-small cell lung cancerYu-Ze Wang, Ning Gao, Zhanwen Lin, et al.
Pageof 3